- December 2024 - January 2025
- EDITORIAL
- TRENDS
- FEATURES
- GOING PLACES
Back to December 2024 - January 2025
CBC Group and Abu Dhabi wealth fund buy UCB’s drug business in China
By
Goh Thean Eu
- Abu Dhabi
- Asia
- Singapore
Singapore’s CBC Group, a healthcare-dedicated asset manager with US$11.8 billion of assets, and Abu Dhabi’s sovereign wealth fund Mubadala Investment Company have acquired Belgian biopharmaceutical firm UCB’s neurology and allergy...
To continue reading this article, you need a subscription to view this article.
Log in below or buy a subscription to enjoy unlimited access to www.asiaasset.com's quickly growing 7,000 article database.
- BNP Paribas wins data management mandate from Australia’s UniSuper
- Korean government aid agency opens tender for 20 billion won equity mandate
- Hong Kong retirement group and PwC propose funds-based MPF
- China wealth fund CIC taps Zhang Shaoqing from SSF as vice president
- Hong Kong’s MPF can still invest 10%-plus in US Treasuries despite US rating downgrade
- Philippine lawmakers pass bill to allow civil servants to retire at 56
- Most Malaysian asset managers earn higher profits, Public Mutual led in 2021
- Malaysia’s PNB CEO Jalil Rasheed resigns
- Singapore entities the only ones from Southeast Asia in top ten wealth, pension funds
- Hong Kong’s PCCW Solutions wins eMPF tender
- Malaysia suspends some short selling as coronavirus batters markets
- Thai fund industry records 132.2 billion baht inflows, mostly into China, global equities
- Malaysia plans new civil service pension to ease government’s financial burden
- Singapore’s Temasek helps raise US$430 million for Bahamas-based crypto firm FTX
- Analysis: What made Temasek can Keppel deal?